Shigeru Uehara - Taisho Pharmaceutical President
| TAIPYDelisted Stock | USD 14.00 0.00 0.00% |
President
Mr. Shigeru Uehara was serving as Vice President and Director in TAISHO PHARMACEUTICAL HOLDINGS CO., LTD., as well as President and Representative Director of a subsidiary, TAISHO PHARMACEUTICAL CO., LTD., since June 2015. He used to work for another subsidiary, Taisho Toyama Pharmaceutical Co., Ltd. and another company. since 2015.
| Age | 42 |
| Tenure | 9 years |
| Phone | 81 3 3985 2020 |
| Web | https://www.taisho-holdings.co.jp |
Taisho Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.0183 % which means that it generated a profit of $0.0183 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0345 %, meaning that it generated $0.0345 on every $100 dollars invested by stockholders. Taisho Pharmaceutical's management efficiency ratios could be used to measure how well Taisho Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Saumen Chakraborty | Dr Reddys Laboratories | 58 | |
| David Kinard | Elanco Animal Health | 57 | |
| Trish Hunt | Catalent | 54 | |
| Eliyahu Kalif | Teva Pharma Industries | 51 | |
| Hafrun Fridriksdottir | Teva Pharma Industries | 58 | |
| Gianfranco Nazzi | Teva Pharma Industries | 50 | |
| Atul Saran | Emergent Biosolutions | 51 | |
| Brendan OGrady | Teva Pharma Industries | 53 | |
| Keith Choy | Haleon plc | 55 | |
| Steven Fasman | Catalent | 57 | |
| Charles Lickfold | Catalent | 50 | |
| David Stark | Teva Pharma Industries | 55 | |
| Ramiro Cabral | Elanco Animal Health | 52 | |
| Wetteny Joseph | Catalent | 48 | |
| Richard Daniell | Teva Pharma Industries | 57 | |
| Scott Gunther | Catalent | 52 | |
| Tom PEng | Catalent | 56 | |
| Sarena Lin | Elanco Animal Health | 48 | |
| Anthony Mauro | Viatris | 51 | |
| Rajiv Malik | Viatris | 63 | |
| Alessandro Maselli | Catalent | 52 | |
Management Performance
| Return On Equity | 0.0345 | |||
| Return On Asset | 0.0183 |
Taisho Pharmaceutical Leadership Team
Elected by the shareholders, the Taisho Pharmaceutical's board of directors comprises two types of representatives: Taisho Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Taisho. The board's role is to monitor Taisho Pharmaceutical's management team and ensure that shareholders' interests are well served. Taisho Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Taisho Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Shigeru Uehara, Vice President and Presidentident of Subsidiary, Director | ||
| Shinichi Tanaka, Gen Communications | ||
| Akira Uehara, President Chairman of Subsidiary, Representative Director | ||
| Jinsei Maruyama, Co Officer | ||
| Tetsu Watanabe, Executive Director | ||
| Jun Kuroda, Ex Director | ||
| Ken Uehara, MD Director | ||
| Hideki Iuchi, G Mang | ||
| Hisashi Umeoka, Director |
Taisho Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Taisho Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0345 | |||
| Return On Asset | 0.0183 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 1.27 B | |||
| Shares Outstanding | 327.94 M | |||
| Price To Earning | 20.67 X | |||
| Price To Book | 0.57 X | |||
| Price To Sales | 0.01 X | |||
| Revenue | 268.2 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Taisho Pink Sheet
If you are still planning to invest in Taisho Pharmaceutical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Taisho Pharmaceutical's history and understand the potential risks before investing.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |